Foundayo (orforglipron) is a once-daily oral GLP-1 medication from Eli Lilly. Unlike injectable GLP-1s, it is a pill, and it is one of the three brand-name medications covered under the Medicare GLP-1 Bridge.

Are all strengths of Foundayo covered under the Bridge?

Foundayo is a once-daily tablet that comes in different dose strengths, and the Bridge covers them. Unlike Zepbound, where only the KwikPen is covered, there is no specific formulation to get right on the prescription.

Is Foundayo a pill or an injection?

Foundayo is a once-daily oral tablet. It is one of the covered options for people who would prefer not to inject; Wegovy also comes in a tablet form.

Foundayo and the Medicare GLP-1 Bridge

Foundayo (orforglipron) is a once-daily oral pill covered under the Bridge — taken by mouth, not injected. It comes in a few dose strengths your doctor adjusts over time, and unlike Zepbound, there's no specific formulation you have to make sure the prescription names. If the idea of a weekly shot has been holding you back, it's well worth asking your doctor about — though it's not your only no-needle choice, since Wegovy also comes as a tablet.

Confirmed by CMS (as of June 2026): Foundayo (orforglipron) is one of three brand-name medications covered under the Bridge, alongside Wegovy and the Zepbound KwikPen, for a $50 monthly copay, July 1, 2026–December 31, 2027, for people who meet the published criteria. Source: CMS.

What Foundayo is

Foundayo is Eli Lilly's brand name for orforglipron, a once-daily GLP-1 medication taken as an oral tablet. The practical difference for most people is simple: it's a daily pill rather than a weekly injection. If needle hesitancy or the routine of injections has been a barrier, that's worth raising with your clinician — the Bridge covers Foundayo on the same $50 copay as the injectable options.

On average, the oral pill produced somewhat less weight loss than the injectables in trials — see weight loss and side effects compared for the numbers.

No formulation catch (unlike Zepbound)

Foundayo is a single once-daily tablet — it just comes in different dose strengths your doctor titrates over time, and the Bridge covers them. That's worth knowing only because of the contrast with Zepbound, where the covered form is specifically the KwikPen and a prescription written for vials or single-dose pens gets rejected. With Foundayo there's no particular form to get right on the prescription; the only real question is whether it's medically appropriate for you.

Already on a GLP-1? Your starting BMI counts

If you're switching from another GLP-1 — or from a self-pay program — the criteria look at your BMI at the time GLP-1 therapy started, not today's number. Pull your starting weight from chart notes or your pharmacy history so your doctor has it. And paying cash in the past (LillyDirect, NovoCare, or compounding pharmacies) does not disqualify you; only receiving a GLP-1 through your Part D plan routes you elsewhere.

Bridge or Part D? Know your lane

The Bridge is for weight management. If you have type 2 diabetes, moderate-to-severe sleep apnea, or certain fatty-liver disease, your doctor may route the request through your regular Part D plan instead. Walking in clear about your diagnoses helps your clinician code it correctly the first time — our Bridge vs. Part D guide breaks this down.

What to bring your doctor

Current height and weight, plus your weight when you started a GLP-1 (if applicable)
That you're interested in Foundayo specifically, the once-daily pill
Diagnoses relevant to the criteria pathways (and your sleep-study severity, if applicable)
Your Medicare drug plan card
The program's prescribing steps — most clinics are seeing the Bridge for the first time

Frequently asked questions

What is Foundayo?

Foundayo (orforglipron) is a once-daily oral GLP-1 medication from Eli Lilly — a pill, not an injection — and one of the three brand-name medications covered under the Bridge.

Are all strengths of Foundayo covered?

Foundayo is a once-daily tablet that comes in different dose strengths, and the Bridge covers them — there's no specific formulation to get right like there is with Zepbound's KwikPen.

Is Foundayo a pill or a shot?

A once-daily oral tablet. It's one of the covered no-injection options — Wegovy also comes as a tablet, so you and your doctor have a choice.

Sources and review status: Content reviewed June 27, 2026, based on published CMS materials including the prescriber fact sheet (CMS Product No. 12235). Foundayo is the brand name for orforglipron (Eli Lilly). Check current CMS materials: CMS Bridge overview, beneficiary fact sheet (PDF), provider information.

Next step: run the free screener — it handles the starting-BMI rule and the Bridge-vs-Part D routing automatically and writes your doctor message for you.